Primary adrenal insufficiency

Patients should receive replacement therapy for life. Adherence to treatment is high, since non-compliance results in uncomfortable symptoms. Furthermore, patients know that non-compliance is potentially life-threatening.

Although the replacement doses try to replicate physiological glucocorticoid and mineralocorticoid secretion, some patients complain of persistent fatigue and decreased well-being.